{"id":"https://openalex.org/W2081177451","doi":"https://doi.org/10.1159/000337415","title":"Advanced Gastroesophageal Carcinoma: An Update on the Current Therapeutic Landscape","display_name":"Advanced Gastroesophageal Carcinoma: An Update on the Current Therapeutic Landscape","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2081177451","doi":"https://doi.org/10.1159/000337415","mag":"2081177451","pmid":"https://pubmed.ncbi.nlm.nih.gov/22488092"},"language":"en","primary_location":{"id":"doi:10.1159/000337415","doi":"https://doi.org/10.1159/000337415","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000337415","pdf_url":null,"source":{"id":"https://openalex.org/S4210228507","display_name":"Onkologie","issn_l":"0378-584X","issn":["0378-584X","1423-0240"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Onkologie","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101883600","display_name":"Yuki Hayashi","orcid":"https://orcid.org/0000-0001-8935-5382","observed_orcids":["https://orcid.org/0000-0001-8935-5382"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuki Hayashi","raw_affiliation_strings":["Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027873506","display_name":"Mariela Anabel Blum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mariela A. Blum","raw_affiliation_strings":["Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044064524","display_name":"Jaffer A. Ajani","orcid":"https://orcid.org/0000-0001-9946-0629","observed_orcids":["https://orcid.org/0000-0001-9946-0629"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaffer A. Ajani","raw_affiliation_strings":["Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":0.515,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.73500293,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"35","issue":"4","first_page":"204","last_page":"209"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.7954000234603882,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.7954000234603882,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.20180000364780426,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11658","display_name":"Esophageal and GI Pathology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gastroesophageal-cancer","display_name":"gastroesophageal cancer","score":0.7850000262260437},{"id":"https://openalex.org/keywords/first-line-chemotherapy","display_name":"first-line chemotherapy","score":0.6869999766349792},{"id":"https://openalex.org/keywords/fluoropyrimidine","display_name":"fluoropyrimidine","score":0.8920000195503235},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9629999995231628},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.8339999914169312},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.9919999837875366},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9919999837875366},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9290000200271606},{"id":"https://openalex.org/keywords/her2-overexpression","display_name":"HER2 overexpression","score":0.8159999847412109},{"id":"https://openalex.org/keywords/survival-disparities","display_name":"survival disparities","score":0.4480000138282776},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6330000162124634}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8216700553894043},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.7141082882881165},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6898912787437439},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.6860247850418091},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6650053262710571},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5927432775497437},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5191140174865723},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.4452313184738159},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3439074456691742},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22681325674057007},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.09173187613487244},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004938","descriptor_name":"Esophageal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004938","descriptor_name":"Esophageal Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000337415","doi":"https://doi.org/10.1159/000337415","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000337415","pdf_url":null,"source":{"id":"https://openalex.org/S4210228507","display_name":"Onkologie","issn_l":"0378-584X","issn":["0378-584X","1423-0240"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Onkologie","raw_type":"journal-article"},{"id":"pmid:22488092","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22488092","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Onkologie","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2770819843","https://openalex.org/W2036755924","https://openalex.org/W2080852612","https://openalex.org/W2755146592","https://openalex.org/W2139028366","https://openalex.org/W2572709096","https://openalex.org/W2140303115","https://openalex.org/W2461775305","https://openalex.org/W1946629818","https://openalex.org/W2034153140"],"abstract_inverted_index":{"Gastroesophageal":[0],"cancers":[1],"are":[2,140],"usually":[3],"diagnosed":[4],"in":[5,34,149,171],"an":[6,99],"advanced":[7,46],"stage,":[8],"and":[9,109,114,136,145],"effective":[10],"treatment":[11,193],"options":[12],"remain":[13],"limited.":[14],"The":[15,73],"discovery":[16],"of":[17,75,86,118,161,179,194],"new":[18,70],"drugs":[19],"to":[20,68,101,134,143,182],"treat":[21],"these":[22],"diseases":[23],"has":[24],"been":[25,62],"slow":[26],"for":[27],"decades.":[28],"An":[29],"occasional":[30],"favorable":[31],"outcome,":[32],"trastuzumab,":[33],"patients":[35,173],"with":[36],"HER2":[37],"protein-overexpressing":[38],"tumors,":[39],"is":[40,96,112,115],"welcome":[41],"but":[42],"not":[43],"sufficient.":[44],"For":[45],"gastroesophageal":[47],"adenocarcinoma":[48],"(AGC),":[49],"fluoropyrimidines":[50],"(given":[51],"orally":[52],"or":[53,80,152,174],"intravenously)":[54],"plus":[55],"a":[56,65,76,106,188],"platinum":[57],"compound":[58],"(usually":[59],"cisplatin)":[60],"have":[61],"accepted":[63],"as":[64,98],"global":[66],"reference":[67],"streamline":[69],"drug":[71],"development.":[72],"addition":[74],"third":[77],"cytotoxic":[78],"(docetaxel":[79],"epirubicin)":[81],"can":[82],"produce":[83],"modest":[84],"prolongation":[85],"overall":[87],"survival.":[88],"In":[89],"some":[90],"European":[91],"countries,":[92],"the":[93,116,192],"irinotecanbased":[94],"regimen":[95,111],"considered":[97],"alternative":[100],"platinum-based":[102],"first-line":[103],"therapy.":[104],"Selecting":[105],"safe,":[107],"effective,":[108],"convenient":[110],"desirable":[113],"focus":[117],"current":[119],"research.":[120],"Additionally,":[121],"it":[122],"appears":[123],"that":[124],"survival":[125],"differences":[126,148],"by":[127],"regions":[128],"(e.g.,":[129],"Asians":[130],"survive":[131],"longer":[132],"compared":[133],"Western":[135],"South":[137],"American":[138],"patients)":[139],"likely":[141],"due":[142],"second-":[144],"third-line":[146],"therapies,":[147],"tumor":[150],"biology,":[151],"unknown":[153],"reasons.":[154],"Future":[155],"progress":[156],"could":[157],"come":[158],"from":[159],"1":[160],"2":[162],"approaches:":[163],"(1)":[164],"conducting":[165],"many":[166],"empiric":[167],"phase":[168],"III":[169],"trials":[170],"unselected":[172],"(2)":[175],"through":[176],"detailed":[177],"studies":[178],"molecular":[180],"biology":[181],"develop":[183],"rational":[184],"therapies.":[185],"We":[186],"provide":[187],"brief":[189],"update":[190],"on":[191],"AGC.":[195]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}